ConductScience.org, home

Paper334342

Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.

Tougaard L and 5 others. Calcif Tissue Res, 1977. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure. Papers, record 334342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/334342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.
PubMed
Journal
Calcif Tissue Res
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-10-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tougaard LL
2Sörensen EE
3Bröchner-Mortensen JJ
4Christensen MSM S
5Rödbro PP
6Sörensen AWA W

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
Kidney Failure, ChronicMajor topic
Bone and Bones
Calcium
Clinical Trials as Topic
Glomerular Filtration Rate
Humans
Hydroxyproline
Parathyroid Hormone
Phosphates

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14629674A simple method for the determination of glomerular filtration rate.Scand J Clin Lab Invest1972https://conductscience.org/library/papers/4629674PubMed
2959749A sensitive radioimmunoassay of parathyroid hormone in human serum using a specific extraction procedure.Scand J Clin Lab Invest1976https://conductscience.org/library/papers/959749PubMed
357505Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.Lancet1976https://conductscience.org/library/papers/57505PubMed
443597391,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.Ann Intern Med1974https://conductscience.org/library/papers/4359739PubMed
51188290Bone mineral content in the forearm measured by photon absorptiometry. Principles and reliability.Scand J Clin Lab Invest1975https://conductscience.org/library/papers/1188290PubMed
61120218I alpha-hydroxycholecalciferol: a treatment of renal bone disease.Br Med J1975https://conductscience.org/library/papers/1120218PubMed
757451Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.Lancet1976https://conductscience.org/library/papers/57451PubMed
81153925The degree of mineralization in normal bone tissue estimated as the phosphorus to hydroxyproline ratio.Scand J Clin Lab Invest1975https://conductscience.org/library/papers/1153925PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/334342

GET https://conductscience.org/api/papers/v1/334342/authors